avapro has been researched along with Anterior Fascicular Block in 1 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cannon, JA | 1 |
| Shen, L | 1 |
| Jhund, PS | 1 |
| Anand, IS | 1 |
| Komajda, M | 1 |
| McKelvie, RS | 1 |
| Zile, MR | 1 |
| Carson, PE | 1 |
| McMurray, JJ | 1 |
1 other study available for avapro and Anterior Fascicular Block
| Article | Year |
|---|---|
Clinical outcomes according to QRS duration and morphology in the irbesartan in patients with heart failure and preserved systolic function (I-PRESERVE) trial.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Bundle-Branch Block; Cause of Dea | 2016 |